IGHE and neoplasm: These results suggest that both anti-CSPG4 IgG and anti-CSPG4 IgE displayed similar and specific affinity for the CSPG4-expressing tumor and that differences in tumor accumulation may be due to other factors affecting their pharmacokinetics.